VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+12.8%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$237M
AUM Growth
-$4.18M
(-1.7%)
Cap. Flow
-$15.8M
Cap. Flow
% of AUM
-6.66%
Top 10 Holdings %
Top 10 Hldgs %
7.93%
Holding
416
New
61
Increased
247
Reduced
47
Closed
61
Top Buys
| 1 |
EOG Resources
EOG
|
$2.02M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$1.99M |
| 3 |
ConocoPhillips
COP
|
$1.85M |
| 4 |
Imperial Oil
IMO
|
$1.8M |
| 5 |
Reliance Steel & Aluminium
RS
|
$1.76M |
Top Sells
| 1 |
Ryman Hospitality Properties
RHP
|
$2.57M |
| 2 |
Western Midstream Partners
WES
|
$2.52M |
| 3 |
INN
Summit Hotel Properties
INN
|
$2.43M |
| 4 |
Brookfield Renewable
BEPC
|
$2.38M |
| 5 |
Grupo Aeroportuario del Pacifico
PAC
|
$2.16M |
Sector Composition
| 1 | Healthcare | 30.46% |
| 2 | Real Estate | 18.03% |
| 3 | Energy | 13.68% |
| 4 | Materials | 11.34% |
| 5 | Utilities | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Prothena Corp
PRTA
$460M
| $593K | 0.25% |
23,598
+423
| +2% | +$10.6K |
|
127
Regeneron Pharmaceuticals
REGN
$60.8B
| $590K | 0.25% |
1,247
+31
| +3% | +$14.7K |
|
128
Vertex Pharmaceuticals
VRTX
$102B
| $589K | 0.25% |
2,739
+71
| +3% | +$15.3K |
|
129
Ionis Pharmaceuticals
IONS
$9.76B
| $588K | 0.25% |
13,084
+359
| +3% | +$16.1K |
|
130
Incyte
INCY
$16.9B
| $585K | 0.25% |
7,204
+193
| +3% | +$15.7K |
|
131
MidCap Financial Investment
MFIC
$1.22B
| $583K | 0.25% |
42,505
-12,389
| -23% | -$170K |
|
132
BlackRock TCP Capital
TCPC
$616M
| $579K | 0.24% |
41,836
+2,395
| +6% | +$33.1K |
|
133
Ironwood Pharmaceuticals
IRWD
$188M
| $574K | 0.24% |
51,311
+1,403
| +3% | +$15.7K |
|
134
Dynavax Technologies
DVAX
$1.18B
| $571K | 0.24% |
58,090
+1,028
| +2% | +$10.1K |
|
135
BioMarin Pharmaceuticals
BMRN
$11.1B
| $570K | 0.24% |
7,550
+204
| +3% | +$15.4K |
|
|
MORF
136
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $565K | 0.24% |
8,928
+150
| +2% | +$9.49K |
|
137
Fidus Investment
FDUS
$757M
| $553K | 0.23% |
35,532
+3,112
| +10% | +$48.4K |
|
|
PNNT
138
Pennant Park Investment Corp
PNNT
$471M
| $549K | 0.23% |
97,135
-40,625
| -29% | -$230K |
|
139
Insmed
INSM
$30.7B
| $534K | 0.23% |
15,678
+426
| +3% | +$14.5K |
|
140
Oaktree Specialty Lending
OCSL
$1.23B
| $531K | 0.22% |
28,547
+11,992
| +72% | +$223K |
|
141
Moderna
MRNA
$9.78B
| $528K | 0.22% |
4,031
+106
| +3% | +$13.9K |
|
142
WhiteHorse Finance
WHF
$204M
| $528K | 0.22% |
34,775
+6,198
| +22% | +$94.1K |
|
|
BPMC
143
DELISTED
Blueprint Medicines
BPMC
| $519K | 0.22% |
5,334
+146
| +3% | +$14.2K |
|
144
Capital Southwest
CSWC
$1.28B
| $506K | 0.21% |
22,813
-4,374
| -16% | -$97K |
|
145
Harmony Biosciences
HRMY
$2.07B
| $506K | 0.21% |
15,322
+423
| +3% | +$14K |
|
146
New Mountain Finance
NMFC
$1.13B
| $502K | 0.21% |
40,512
+2,818
| +7% | +$34.9K |
|
147
Goldman Sachs BDC
GSBD
$1.31B
| $500K | 0.21% |
25,885
+4,853
| +23% | +$93.7K |
|
|
BGX
148
Blackstone Long-Short Credit Income Fund
BGX
$160M
| $493K | 0.21% |
34,869
+3,439
| +11% | +$48.6K |
|
|
DCPH
149
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $492K | 0.21% |
10,979
+298
| +3% | +$13.4K |
|
|
BHVN
150
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $492K | 0.21% |
7,193
+196
| +3% | +$13.4K |
|